CUSI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 11.076
EU - Europa 9.931
AS - Asia 1.535
SA - Sud America 26
OC - Oceania 22
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 19
Totale 22.630
Nazione #
US - Stati Uniti d'America 11.030
GB - Regno Unito 2.581
IE - Irlanda 2.032
IT - Italia 1.413
CN - Cina 1.108
UA - Ucraina 970
SE - Svezia 964
FR - Francia 563
DE - Germania 548
FI - Finlandia 323
RU - Federazione Russa 301
SG - Singapore 134
VN - Vietnam 79
ES - Italia 69
TR - Turchia 60
IN - India 51
BE - Belgio 42
CA - Canada 37
CZ - Repubblica Ceca 29
EU - Europa 19
HK - Hong Kong 19
AU - Australia 16
AT - Austria 13
JP - Giappone 13
NL - Olanda 13
PL - Polonia 10
IM - Isola di Man 9
IR - Iran 9
KR - Corea 9
BR - Brasile 8
CL - Cile 8
IQ - Iraq 8
RS - Serbia 8
SA - Arabia Saudita 7
GH - Ghana 6
GR - Grecia 6
NZ - Nuova Zelanda 6
PH - Filippine 6
BD - Bangladesh 5
CH - Svizzera 5
MT - Malta 5
PA - Panama 5
PK - Pakistan 5
ID - Indonesia 4
MW - Malawi 4
PE - Perù 4
SC - Seychelles 4
AM - Armenia 3
PT - Portogallo 3
TH - Thailandia 3
ZA - Sudafrica 3
AR - Argentina 2
BG - Bulgaria 2
BZ - Belize 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
UZ - Uzbekistan 2
VE - Venezuela 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
EC - Ecuador 1
HR - Croazia 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
ME - Montenegro 1
MY - Malesia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 22.630
Città #
Southend 2.334
Dublin 1.996
Fairfield 1.564
Chandler 1.144
Ashburn 889
Woodbridge 799
Jacksonville 782
Wilmington 649
Seattle 647
Houston 572
Cambridge 556
Ann Arbor 501
Siena 466
Princeton 346
Nanjing 271
Menlo Park 244
Beijing 243
Helsinki 155
New York 145
Boardman 130
San Mateo 116
Nanchang 100
San Diego 92
Moscow 85
Fremont 76
Dong Ket 67
Singapore 66
Rome 62
Dearborn 57
Málaga 57
Shanghai 55
Shenyang 53
Hebei 51
Florence 50
Izmir 45
London 44
Tianjin 43
Norwalk 41
Brussels 39
Milan 35
Kunming 33
Lancaster 33
Jiaxing 31
Venezia 31
Changsha 29
San Francisco 28
Los Angeles 24
Toronto 24
Jinan 23
Washington 23
Munich 22
Lappeenranta 20
Redwood City 19
Auburn Hills 16
Ningbo 16
Guangzhou 15
Padova 15
Düsseldorf 14
Hangzhou 14
Iesi 14
Zhengzhou 14
Brno 13
Vienna 13
Hong Kong 12
Taizhou 12
Frankfurt am Main 11
Hounslow 11
Lanzhou 11
Olomouc 10
Palermo 10
Cagliari 9
Falls Church 9
Haikou 9
Hefei 9
Kilburn 9
Belgrade 8
Douglas 8
Edinburgh 8
Fuzhou 8
Mestre 8
Philadelphia 8
Pontedera 8
Hanoi 7
Madrid 7
Messina 7
Paris 7
Tokyo 7
Trieste 7
Bari 6
Changchun 6
Falkenstein 6
Hanover 6
Montreal 6
Phoenix 6
Saint Petersburg 6
San Jose 6
Sydney 6
Turin 6
Athens 5
Bangalore 5
Totale 16.441
Nome #
ERITEMA NODOSO RECIDIVANTE E PERSISTENTE REPLICA DI EPSTEIN-BARR VIRUS 270
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 241
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 233
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 227
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 226
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 219
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 199
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 194
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 192
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 191
Valutazione di un test in chemiluminescenza per la diagnosi sierologica di Leishmaniosi Viscerale 187
Peptidi epitopici immunogenici del CEA da utilizzare nella chemio-immunoterapia del carcinoma del colon-retto e della mammella. 182
Peripheral biomarkers' panel for severe COVID-19 patients 182
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 180
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 176
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 172
Serological evidence of reinfection among vaccinees during rubella outbreak 168
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 167
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 167
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 166
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 165
In vitro neuraminidase inhibitory effect and activity against influenza virus A H1N1 of herbal drugs used for common cold 165
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 159
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 156
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis 152
Testicular involvement during Toscana-virus infection: an unusual manifestation? 151
HCMV infection in renal transplant recipients: a retrospective cohort study 151
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 149
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 148
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 148
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 145
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 142
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. 141
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 141
FIBRILLO-FLUTTER IN ASSENZA DI SEGNI DI MIOCARDITE IN CORSO DI INFEZIONE DA EBV 140
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 140
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 139
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 139
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 139
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 138
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 135
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. 135
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 135
Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 134
Tumour associated antigen (TAA) specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes 133
Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells 131
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus. 130
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 130
Biotechnology for virus vaccine design, production, and control 128
Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine 127
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector. 126
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 126
Effetti della dieta sulla secrezione di calcitonina nel neonato [The effects of diet on the secretion of calcitonin in the newborn infant] 125
Diagnostic tools for Toscana virus infection. 122
Synthetic peptides of rubella E1 glycoprotein for serological assays 122
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 122
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 122
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile 122
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects 121
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 121
SARS-CoV-2 in pleural fluid in a kidney transplant patient 119
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 118
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 117
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 117
Serial KL-6 measurements in COVID-19 patients 117
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients. 116
Histological description of the lymphadenopathy related to Toscana virus infection. Report of a case. 115
Applications of Influenza Virosomes as a delivery system 115
Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. 115
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases 114
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them. 114
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 114
Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: children and elderly 114
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 114
Epidemiological and clinical study of viral respiratory tract infections in children from Italy 113
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 113
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 113
Pathogenic mechanism of Helicobacter pylori: production of cytoxin 113
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine 112
null 112
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 112
Rapid detection of different RNA respiratory virus species by multiplex RT-PCR: application to clinical specimens 111
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 110
RSV and HMPV seroprevalence in Tuscany (Italy) and North-Rhine Westfalia (Germany) in the winter season 2009/2010 110
Encephalitis without meningitis due to sandfly fever virus serotype toscana 110
Recombinant Nucleoprotein of Toscana virus. 109
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse 109
Bayesian skyline plot inference of the Toscana virus epidemic: a decline in the effective number of infections over the last 30 years 109
Pathogenic mechanisms of Helicobacter pylori: production of cytotoxin. 109
Neutralization of Toscana virus is partially mediated by antibodies to the nucleocapsid protein 109
Potential of DNA vaccines delivered by influenza virosomes 108
Editorial overview: Anti-infectives: Towards novel antiviral and antibacterial drugs? Current approaches to address a growing medical need 108
Toscana Virus Nucleoprotein” () 107
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase 107
Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia. 106
A Mediterranean arbovirus: the Toscana virus 106
null 106
Models of active specific immuno-therapy of human malignancy bone metastases. 105
Editorial: arthropod-borne viruses and emergent viruses. 105
Development of a mouse model for the study of Toscana virus pathogenesis 105
Totale 13.890
Categoria #
all - tutte 74.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.501


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.722 0 142 297 676 271 305 376 568 345 368 101 273
2020/20213.786 158 407 108 343 236 540 191 506 438 289 279 291
2021/20222.638 166 275 145 214 128 89 127 142 221 283 252 596
2022/20234.158 259 333 522 552 416 841 84 355 431 104 171 90
2023/20243.168 111 108 268 184 104 832 1.086 75 18 77 68 237
2024/2025404 184 220 0 0 0 0 0 0 0 0 0 0
Totale 23.009